Jackson Garth is an executive leader who focuses on strategic growth, healthcare innovation, private equity, and economic development. He is a distinguished executive, entrepreneur, and growth strategist with nearly three decades of experience driving revenue growth, market expansion, organizational scaling, and business transformation across healthcare, biotechnology, life sciences, private equity, transportation, agriculture, and emerging industries. Throughout his career, he has consistently demonstrated the ability to identify opportunities, build high-performing teams, create scalable infrastructure, and deliver sustainable growth in highly competitive markets.

Jackson's career foundation was established within the healthcare sector, where he spent nearly twenty years building an exceptional track record of sales and leadership success. At Pfizer Pharmaceuticals, he led the Southeast Region in the antifungal and antibiotic markets, establishing himself as a top-performing sales professional early in his career. At Gilead Sciences, he ranked among the Top 10 sales professionals nationally for antiretroviral medicines before advancing into leadership and earning recognition as a Top 3 Regional Sales Manager in the nation.

Continuing his trajectory of excellence, Jackson served as Regional Sales Manager for Stryker, where he consistently ranked among the company's Top 2 Sales Managers nationally for three consecutive years. He later joined ProPath Laboratories and spearheaded the company's Southeast expansion, growing the organization from a single representative in Georgia to a network of more than 30 representatives throughout the region.

As Vice President of Business Development for Centurion Medical Supplies, Jackson created dedicated distribution and sales channels that generated consistent year-over-year growth, increasing company sales by more than 20 percent annually. His success in business development and market expansion led to executive leadership roles with La Boveda and Verde Leaf, where he directed licensing initiatives, developed products and brands, and built the sales infrastructure necessary to support scalable growth within emerging markets.

Jackson further expanded his leadership impact within biotechnology and life sciences through executive roles with Severus Biotech and Neurogentics. Working alongside executive leadership teams, he helped shape organizational vision, strategic direction, and ecosystem development initiatives designed to accelerate innovation and commercial growth within the life sciences sector.

His expertise spans strategic planning, business development, capital growth, market expansion, operational leadership, organizational scaling, partnership development, healthcare commercialization, private equity, and ecosystem creation. Known for his ability to connect vision with execution, Jackson has built a career centered on transforming ideas into thriving organizations and sustainable enterprises.

A graduate of Morehouse College, Jackson earned a Bachelor of Arts in Business Administration before completing both a Master of Business Administration and a Doctor of Business Administration from Canterbury Christ Church University.

Jackson Garth's career reflects a commitment to innovation, leadership, and economic advancement. Through his work across healthcare, biotechnology, private equity, and global development initiatives, he continues to build organizations, industries, and partnerships that create lasting impact and measurable value.